DK0391625T3 - Substituerede chromaner til behandling af astma, arthritis og beslægtede sygdomme - Google Patents

Substituerede chromaner til behandling af astma, arthritis og beslægtede sygdomme

Info

Publication number
DK0391625T3
DK0391625T3 DK90303443.7T DK90303443T DK0391625T3 DK 0391625 T3 DK0391625 T3 DK 0391625T3 DK 90303443 T DK90303443 T DK 90303443T DK 0391625 T3 DK0391625 T3 DK 0391625T3
Authority
DK
Denmark
Prior art keywords
arthritis
substituted
chromana
related diseases
treat asthma
Prior art date
Application number
DK90303443.7T
Other languages
Danish (da)
English (en)
Inventor
James Frederick Eggler
Hiroko Masamune
Anthony Marfat
Lawrence Sherman Melvin Jr
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of DK0391625T3 publication Critical patent/DK0391625T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pulmonology (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Pyridine Compounds (AREA)
DK90303443.7T 1989-04-07 1990-03-30 Substituerede chromaner til behandling af astma, arthritis og beslægtede sygdomme DK0391625T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1989/001457 WO1990012010A1 (fr) 1989-04-07 1989-04-07 Chromans substitues pour le traitement de l'asthme, de l'arthrite et de maladies apparentees

Publications (1)

Publication Number Publication Date
DK0391625T3 true DK0391625T3 (da) 1994-02-28

Family

ID=22214926

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90303443.7T DK0391625T3 (da) 1989-04-07 1990-03-30 Substituerede chromaner til behandling af astma, arthritis og beslægtede sygdomme

Country Status (12)

Country Link
US (1) US5298512A (fr)
EP (1) EP0391625B1 (fr)
JP (1) JPH0753726B2 (fr)
AT (1) ATE100804T1 (fr)
CA (1) CA2013894A1 (fr)
DE (1) DE69006243T2 (fr)
DK (1) DK0391625T3 (fr)
ES (1) ES2062345T3 (fr)
FI (1) FI914683A0 (fr)
IE (1) IE901241L (fr)
PT (1) PT93674A (fr)
WO (1) WO1990012010A1 (fr)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2676056B1 (fr) * 1991-05-03 1993-07-16 Adir Nouveaux derives du benzopyranne leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
US5149703A (en) * 1991-09-06 1992-09-22 Merck Frosst Canada, Inc. Quinoline-substituted chromans and related compounds as leukotriene antagonists
MX9300312A (es) * 1992-01-23 1993-07-31 Pfizer Antagonistas benzopiranicos y relacionado de ltb.
US5451603A (en) * 1993-03-11 1995-09-19 Zymogenetics, Inc. 3,4-diarylchromans for treatment of dermatitis
US5698550A (en) * 1993-06-14 1997-12-16 Pfizer Inc. Tetralin and chroman derivatives useful in the treatment of asthma, arthritis and related diseases
US5482942A (en) * 1994-06-28 1996-01-09 American Home Products Corporation (3,4-dioxocyclobuten-1-yl)chromene, indene, and dihydronaphthalenone derivatives as smooth muscle relaxants
US5952326A (en) * 1997-12-10 1999-09-14 Pfizer Inc. Tetralin and chroman derivatives useful in the treatment of asthma, arthritis and related diseases
AU5666800A (en) 1999-06-22 2001-01-09 Mount Sinai Hospital Corporation Difuropyrone derivatives
US20060019269A1 (en) * 2002-10-17 2006-01-26 Decode Genetics, Inc. Susceptibility gene for myocardial infarction, stroke, and PAOD, methods of treatment
WO2005027886A2 (fr) * 2003-09-17 2005-03-31 Decode Genetics Ehf. Methodes de prevention ou de traitement de la recurrence de l'infarctus du myocarde
CA2502357A1 (fr) * 2002-10-17 2004-04-29 Decode Genetics Ehf. Gene de susceptibilite pour l'infarctus du myocarde, et procedes de traitement
US20080293750A1 (en) * 2002-10-17 2008-11-27 Anna Helgadottir Susceptibility Gene for Myocardial Infarction, Stroke, Paod and Methods of Treatment
US7851486B2 (en) * 2002-10-17 2010-12-14 Decode Genetics Ehf. Susceptibility gene for myocardial infarction, stroke, and PAOD; methods of treatment
US7507531B2 (en) * 2002-10-17 2009-03-24 Decode Genetics Chf. Use of 5-lipoxygenase activating protein (FLAP) gene to assess susceptibility for myocardial infarction
US8158362B2 (en) * 2005-03-30 2012-04-17 Decode Genetics Ehf. Methods of diagnosing susceptibility to myocardial infarction and screening for an LTA4H haplotype
US20100216863A1 (en) * 2004-01-30 2010-08-26 Decode Genetics Ehf. Susceptibility Gene for Myocardial Infarction, Stroke, and PAOD; Methods of Treatment
SG175390A1 (en) 2009-04-29 2011-12-29 Amarin Corp Plc Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same
WO2016122500A1 (fr) 2015-01-28 2016-08-04 Smith & Nephew, Inc. Système de résection de tissu
CA2989162A1 (fr) 2015-06-18 2016-12-22 Covidien Lp Instrument chirurgical avec commande d'aspiration
CA3035999C (fr) * 2017-09-07 2021-01-05 Syaulan S. YANG Derives heterocycliques de benzene fusionne et composition pharmaceutique renfermant lesdits derives
US11883058B2 (en) 2019-03-26 2024-01-30 Covidien Lp Jaw members, end effector assemblies, and ultrasonic surgical instruments including the same
WO2021198283A1 (fr) * 2020-03-31 2021-10-07 Janssen Pharmaceutica Nv Inhibiteurs de présentation d'antigène par hla-dr

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3553093A (en) * 1965-03-19 1971-01-05 Xerox Corp Color photoelectrophoretic imaging process
US3936461A (en) * 1973-09-24 1976-02-03 Warner-Lambert Company Substituted 4-benzylquinolines
US4127669A (en) * 1977-10-13 1978-11-28 Warner-Lambert Company [(4-Oxo-4H-1-benzopyran-3-yl)oxy] acetic acids and derivatives
US4563468A (en) * 1979-09-13 1986-01-07 Burroughs Wellcome Co. Chemotherapeutic agents
DE3479726D1 (de) * 1983-05-18 1989-10-19 Beecham Group Plc Benzopyran derivatives.
US4661596A (en) * 1985-02-21 1987-04-28 American Home Products Corporation Quinolinyl (or pyridinyl) methoxy substituted naphthalene compounds as antiallergic agents
US4642347A (en) * 1985-05-21 1987-02-10 American Home Products Corporation 3(2-quinolinylalkoxy)phenols
US4889941A (en) * 1987-04-23 1989-12-26 Fisons Corporation Synthetic flavonoids as inhibitors of leukotrienes and 5-lipoxygenase
US4889871A (en) * 1987-05-29 1989-12-26 G. D. Searle & Co. Alkoxy-substituted dihydrobenzopyran-2-carboxylate derivatives
MX13485A (es) * 1987-10-19 1993-05-01 Pfizer Procedimiento para obtener tetralinas, cromados y compuestos relacionados, sustituidos

Also Published As

Publication number Publication date
PT93674A (pt) 1990-11-20
ES2062345T3 (es) 1994-12-16
US5298512A (en) 1994-03-29
IE901241L (en) 1990-10-07
DE69006243T2 (de) 1994-05-05
EP0391625B1 (fr) 1994-01-26
EP0391625A1 (fr) 1990-10-10
JPH02290869A (ja) 1990-11-30
WO1990012010A1 (fr) 1990-10-18
ATE100804T1 (de) 1994-02-15
FI914683A7 (fi) 1991-10-04
JPH0753726B2 (ja) 1995-06-07
FI914683A0 (fi) 1991-10-04
DE69006243D1 (de) 1994-03-10
CA2013894A1 (fr) 1990-10-07

Similar Documents

Publication Publication Date Title
DK0391625T3 (da) Substituerede chromaner til behandling af astma, arthritis og beslægtede sygdomme
MY104341A (en) Substituted tetralins,chromans and related compounds in the treatment of asthma,arthritis and related diseases
BRPI9917862B8 (pt) dihidropirimidinas, bem como processo para a preparação e aplicação das mesmas.
DE69328474D1 (de) Verwendung von substituierten Adeninderivaten zur Behandlung von MultipleSklerose
BR0015533A (pt) Iduronidase-alfa-l recombinante, métodos para sua produção e purificação e métodos para tratamento de doenças causadas por deficiências da mesma
MX9205532A (es) Nuevas 7-sustituidas-9-amino sustituidas 6-desmetil-6-desoxitetraciclinas, metodo para su producciony composicion farmaceutica que las contiene.
DK0398753T3 (da) Metalloproteinasehæmmer
DK0726892T3 (da) (E)-20(22)-dehydrovitamin D-forbindelser
BG107537A (bg) Инхибиране на човешка tnf алфа активност
FR2543145B1 (fr) Nouveaux sulfates de xylanes, leur procede de preparation et leur activite anti-thrombotique et hypolipemiante
FI952148L (fi) Geenitekninen menetelmä ja isäntä ksylitolin valmistamiseksi
YU46963B (sh) Postupak za dobijanje supstituisanih tetralina hromana i srodnih jedinjenja
DE69130497D1 (de) Neue Verwendung von 1-Alpha-hydroxylierten-19-nor-vitamin-D-Verbindungen zur Behandlung von Psoriasis
ES2109229T3 (es) Sulfonamidas sustituidas y compuestos relacionados para el tratamiento del asma, la artritis y enfermedades relacionadas.
ES2063261T3 (es) 1-(3-(heteroarilmetoxi)fenil) alcanoles sustituidos y compuestos relacionados en el tratamiento de asma, artritis y enfermedades relacionadas.
DE69822202D1 (de) Herstellung von alkylmonohydrogenhalogensilanen durch redistribution und destillation
ATE206394T1 (de) Neue vitamin-d-analoga
ITTO930166A1 (it) Procedimento per il trattamento di flussi reflui della produzione di n-fosfonometilglicina.
SE9300686D0 (sv) Novel polypeptides